openPR Logo
Press release

Europe In Vitro Diagnostics (IVD) Market Size Reach $15.5 Billion, Owing To Enhanced Usage In Hospitals Sector Till 2024: Grand View Research, Inc

08-31-2016 11:01 AM CET | Health & Medicine

Press release from: Grand View Research, Inc.

Europe In Vitro Diagnostics (IVD) Market Size Reach $15.5

The Europe IVD market (http://www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market)is expected to reach over USD 15.5 billion by 2024 according to a new report by Grand View Research, Inc. This expected increase in the demand is ascribed to the presence of novel and promising technologies in clinical laboratories, such as the introduction of Troponin T test by Roche Diagnostics in May, 2011.
Persistent research and development efforts made to introduce automation in laboratories that perform analytical testsare projected to propel the market growth over the forecast period. Clinical laboratory operations require automated analyzers to cope with the large test volumes,which enhance the overall operational workflow. It minimizes the need for dedicated operator training andnegates the risk of human errors. In addition, the rising demand for portable and handheld IVD devicesis one of the major factors pushing forward the growth of the market.
The increasing prevalence of chronic diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising geriatric population coupled with the rising awareness towards early diagnosis in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe IVD market.
Browse full research report on Global Europe In Vitro Diagnostics (IVD) Market: http://www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market
Further key findings from the study suggest:
• In 2015, the reagents segment dominated the Europe IVD market due to its increasing number of applications in the companion diagnostics area and the introduction of disease specific kits, such as the XpertTB kit
• The IVD instruments market is anticipated to show lucrative growth due to the introduction of portable instruments, such as MinION Analyzer by Oxford Nanopore, and the availability of various platforms to performtarget sequence analysis, thereby driving the overall demand
• Germany is one of the largest segments in 2015 with a share of over 19% owing to the presence of a larger geriatric population base in this region and the amendment ofthe German lawfor the prevention of hospital-acquired infections
• UK is expected to be the fastest growing regionduring the forecast period.The rising demand for the point-of-care devices coupled with the government interventions to incorporate innovative, cost-effective solutions in the healthcare services are expected to drive the market growth during the forecast period.
• The hospital-based IVD testing segment held the largest share of over 45% in 2015. The highprocedure volumes in this segment, is one of the major reasons resulting inthehigh share and;hence, is anticipated to maintain its market position over the forecast period.
• The market players of the Europe IVD market include Alere, Inc., bioMerieux, Inc., Hologic, Inc. (Gen-Probe), Roche Diagnostics, Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Abbott Laboratories, Inc., Becton, Dickinson (BD) and Company, Inc., and Siemens Healthcare GmbH
• The presence of major IVD market players in Europe accelerates the penetration of the IVD products throughout the European Union. For instance, in September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring withenhanced flexibility and automation.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Europe IVD market on the basis of product, technology, application, test location, and region:
Europe In-Vitro Diagnostics (IVD) Market, by Product (USD Million), 2013 - 2024
• IVD Instruments
• IVD Reagents
• Services
• Data Management
Europe In-Vitro Diagnostics (IVD) Market, by Technique (USD Million), 2013 - 2024
• Immunochemistry
• Microbiology
• Molecular diagnostics
• Hematology
• Clinical Chemistry
• Coagulation
• Other Clinical Instruments
Europe In-Vitro Diagnostics (IVD) Market, by Application (USD Million), 2013 - 2024
• Infectious Diseases
• Diabetes
• Oncology/Cancer
• Cardiology
• Nephrology
• Autoimmune Diseases
• Drug Testing
• Others
Europe In-Vitro Diagnostics (IVD) Market, by End-use (USD Million), 2013 - 2024
• Hospitals
• Laboratory
• Patient self-testing
• Point-of-care testing
• Academics
• Others
Europe In-Vitro Diagnostics (IVD) Market, by Country (USD Million), 2013 - 2024
• Germany
• UK
• France
• Switzerland
• Spain
• Italy
• Belgium
• Austria
• Netherlands
• Sweden

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Press Contact
Sherry James - Corporate Relations Specialist
28 2nd Street, Suite 3036
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe In Vitro Diagnostics (IVD) Market Size Reach $15.5 Billion, Owing To Enhanced Usage In Hospitals Sector Till 2024: Grand View Research, Inc here

News-ID: 357900 • Views:

More Releases from Grand View Research, Inc.

Maternal Mental Health Market To Reach $45.72 Billion By 2030 | Therapy Mama, Canopie, Pfizer, Inc., Viatris, Inc.
Maternal Mental Health Market To Reach $45.72 Billion By 2030 | Therapy Mama, Ca …
The global maternal mental health market size is expected to reach USD 45.72 billion by 2030, growing at a CAGR of 28.43%, according to a new report by Grand View Research, Inc. Maternal mental health issues are a global concern that affects women of various countries and cultures. It refers to the emotional well-being of women during the pregnancy and postpartum period. The market is driven by the increasing incidence
Downstream Processing Market Size, Share & Trends Analysis Report, 2030
Downstream Processing Market Size, Share & Trends Analysis Report, 2030
The global downstream processing market size is expected to reach USD 94.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.84% from 2023 to 2030. The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume products has shifted to developing small-volume, high-potency
Electric Mobility Industry: E- Light Commercial Vehicle Thereby Contributing To Creating New Growth Opportunity
Electric Mobility Industry: E- Light Commercial Vehicle Thereby Contributing To …
The global electric mobility industry size stood at USD 101.67 billion in 2022 and will exhibit a CAGR of 19.9% from 2023 to 2030, according to the "Electric Mobility Industry Data Book, 2023 - 2030," published by Grand View Research. The growth comes on the back of an exponential rise in smart cities and a gradual uptick in charging infrastructure. Further, the strong outlook of electric mobility will rely on the launch
Digital Health Market Size, Share & Trends Analysis Report 2030
Digital Health Market Size, Share & Trends Analysis Report 2030
The global digital health market size is expected to reach USD 809.2 billion by 2030. According to a new report by Grand View Research, Inc, it is expected to expand at a CAGR of 18.6% during the forecast period. Rising smartphone adoption, improved internet connectivity with the launching of 4G/5G, advancement in healthcare IT infrastructure, rising healthcare costs, the rising penetration rate of chronic diseases, increasing adoption rate of remote

All 5 Releases


More Releases for IVD

IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Infectious Disease IVD Market – Forecast to 2026
The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market. Browse 159 Market
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical